IP Library Granted Patent US 7,524,286
Granted Patent B2
US 7,524,286 · App. 10/867,990 · Granted Apr 28, 2009

System for combined transcutaneous blood gas monitoring and negative pressure wound treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,524,286
App. No.
10/867,990
Granted
Apr 28, 2009
Kind
B2
Abstract

A method and apparatus for the transcutaneous monitoring of blood gases generally comprises a blood gas data acquisition device, a vacuum source and a blood gas transducer unit. The blood gas transducer unit is adapted for application to a patient's skin and administration of a local vacuum at the area of patient application. It further comprises an electrochemical blood gas transducer, well known to those of ordinary skill in the art, which is disposed entirely within the local vacuum at the area of patient application. The vacuum source is placed in fluid communication with the blood gas transducer unit, through a hydrophobic membrane filter for safety purposes, in order to induce a condition of hyperperfusion in the locality of the electrochemical blood gas transducer. Under the control of a microcontroller, or equivalent means, the blood gas acquisition device is then utilized to capture a measure of skin surface oxygen or carbon dioxide pressure. The microcontroller can then utilize this measure to arrive at an estimate of arterial partial pressure of oxygen or carbon dioxide, accordingly. Because vacuum induced perfusion produces the requisite condition of hyperperfusion without local heating and, therefore, without acceleration of the local metabolic function, the present invention results in more accurate than previously available estimates of partial pressure blood gas pressures and does so while eliminating a significant risk for injury to the patient.

Claims (44)

1. A transcutaneous blood gas monitoring device particularly suited for application to a site on a patient's skin under a local vacuum, comprising:

a non-invasive blood gas data acquisition device, the non-invasive blood gas data acquisition device adapted to measure skin surface oxygen and carbon dioxide pressure;

a vacuum source in fluid communication with a wound site in proximity to the site on the patient's skin for applying a negative pressure to the wound site;

an electrochemical blood gas transducer unit in fluid communication with said vacuum source;

a transducer interface module communicating between the electrochemical blood gas transducer unit, the vacuum source and the non-invasive blood gas data acquisition device and adapted to reduce or eliminate contamination; and

a screen formed to fit within said wound site.

2. The transcutaneous blood gas monitoring device of claim 1 , wherein the vacuum source is in fluid communication with the electrochemical blood gas transducer unit through an interposed vacuum hose.

3. The transcutaneous blood gas monitoring device of claim 2 , wherein the electrochemical blood gas transducer unit is in electrical communication with the non-invasive blood gas data acquisition device through an interposed electrical cable.

4. The transcutaneous blood gas monitoring device of claim 3 , wherein the interposed vacuum hose and the interposed electrical cable comprise a unitary hose and cable pair for reduction of entanglement with other tubes, cables or equipment.

5. The transcutaneous blood gas monitoring device of claim 4 , further comprising a hydrophobic membrane filter interposed in the interposed vacuum hose.

6. The transcutaneous blood gas monitoring device of claim 5 , wherein the hydrophobic membrane filter is disposable.

7. The transcutaneous blood gas monitoring device of claim 3 , wherein the non-invasive blood gas data acquisition device monitors healing of the wound site.

8. The transcutaneous blood gas monitoring device of claim 3 , further comprising:

a seal for maintaining the negative pressure within said wound site during application of negative pressure.

9. The transcutaneous blood gas monitoring device of claim 3 , further comprising a collection canister interposed between the vacuum source and the screen.

10. The transcutaneous blood gas monitoring device of claim 9 , wherein the interposed vacuum hose is bifurcated at a position between the vacuum source and the collection canister to prevent fluids drawn from the wound site from interfering with the electrochemical blood gas transducer unit.

11. The transcutaneous blood gas monitoring device of claim 3 , further comprising a controller for governing actions of said non-invasive blood gas data acquisition device.

12. The transcutaneous blood gas monitoring device of claim 1 , wherein the transducer interface module comprises a male and female interface pair, wherein the male interface is adapted to plug into the female interface and establish communication between the electrochemical blood gas transducer unit, the vacuum source and the non-invasive blood gas acquisition device.

13. The transcutaneous blood gas monitoring device of claim 1 , wherein the vacuum source comprises a vacuum pump operated by a pump motor.

14. The transcutaneous blood gas monitoring device of claim 1 , wherein the electrochemical blood gas transducer unit is incorporated within the screen.

15. The transcutaneous blood gas monitoring device of claim 1 , wherein the screen is in fluid communication with the vacuum source.

16. The transcutaneous blood gas monitoring device of claim 1 , further comprising a second vacuum source adapted to provide negative pressure at the wound site by communicating with the screen.

17. The transcutaneous blood gas monitoring device of claim 1 , wherein the vacuum source is capable of providing suction in a range of about 50 mmHg to about 250 mmHg.

18. A transcutaneous blood gas monitoring device particularly suited for application to a site on a patient's skin under a local vacuum, comprising:

a non-invasive blood gas data acquisition device;

a vacuum source in fluid communication with a wound site in proximity to the site on the patient's skin for applying a negative pressure to the wound site;

an electrochemical blood gas transducer unit in fluid communication with said vacuum source, the electrochemical blood gas transducer unit in electrical communication with the non-invasive blood gas data acquisition device through an interposed electrical cable, and the vacuum source in fluid communication with the electrochemical blood gas transducer unit through an interposed vacuum hose;

a transducer interface module communicating between the electrochemical blood gas transducer unit, the vacuum source and the non-invasive blood gas data acquisition device and adapted to reduce or eliminate contamination;

a screen formed to fit within said wound site; and

a collection canister interposed between the vacuum source and the screen, wherein the interposed vacuum hose is bifurcated at a position between the vacuum source and the collection canister to prevent fluids drawn from the wound site from interfering with the electrochemical blood gas transducer unit.

19. The transcutaneous blood gas monitoring device of claim 18 , wherein the interposed vacuum hose and the interposed electrical cable comprise a unitary hose and cable pair for reduction of entanglement with other tubes, cables or equipment.

20. The transcutaneous blood gas monitoring device of claim 19 , further comprising a hydrophobic membrane filter interposed in the interposed vacuum hose.

21. The transcutaneous blood gas monitoring device of claim 20 , wherein the hydrophobic membrane filter is disposable.

22. The transcutaneous blood gas monitoring device of claim 18 , wherein the non-invasive blood gas data acquisition device monitors healing of the wound site.

23. The transcutaneous blood gas monitoring device of claim 18 , further comprising:

a seal for maintaining the negative pressure within said wound site during application of negative pressure.

24. The transcutaneous blood gas monitoring device of claim 18 , further comprising a controller for governing actions of said non-invasive blood gas data acquisition device.

25. The transcutaneous blood gas monitoring device of claim 18 , wherein the transducer interface module comprises a male and female interface pair, wherein the male interface is adapted to plug into the female interface and establish communication between the electrochemical blood gas transducer unit, the vacuum source and the non-invasive blood gas acquisition device.

26. The transcutaneous blood gas monitoring device of claim 18 , wherein the vacuum source comprises a vacuum pump operated by a pump motor.

27. The transcutaneous blood gas monitoring device of claim 18 , wherein the electrochemical blood gas transducer unit is incorporated within the screen.

28. The transcutaneous blood gas monitoring device of claim 18 , wherein the screen is in fluid communication with the vacuum source.

29. The transcutaneous blood gas monitoring device of claim 18 , further comprising a second vacuum source adapted to provide negative pressure at the wound site by communicating with the screen.

30. The transcutaneous blood gas monitoring device of claim 18 , wherein the non-invasive blood gas data acquisition device is adapted to measure skin surface oxygen and carbon dioxide pressure.

31. The transcutaneous blood gas monitoring device of claim 18 , wherein the vacuum source is capable of providing suction in a range of about 50 mmHg to about 250 mmHg.

Assignments (12)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
RELEASE OF SECURITY INTEREST Recorded Sep 21, 2016
From: WILMINGTON TRUST
To: KCI LICENSING, INC.; LIFECELL CORPORATION; KINETIC CONCEPTS, INC.; TECHNIMOTION, LLC
Reel/Frame 040098/0200 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY AGREEMENT Recorded Nov 8, 2011
From: KCI LICENSING, INC.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 027194/0447 →
SECURITY AGREEMENT Recorded Nov 7, 2011
From: KCI LICENSING, INC.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 027185/0174 →
RELEASE OF SECURITY INTEREST Recorded May 30, 2008
From: CITIBANK, N.A.
To: KINETIC CONCEPTS, INC.; KCI USA, INC.; KCI HOLDING COMPANY, INC.; KCI LICENSING, INC.; KCI INTERNATIONAL, INC.
Reel/Frame 021018/0130 →
SECURITY AGREEMENT Recorded Aug 2, 2007
From: KCI LICENSING, INC.; KINETIC CONCEPTS, INC.; KCI USA, INC.; KCI HOLDING COMPANY, INC.; KCI INTERNATIONAL, INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 019640/0163 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2007
From: MORGAN STANLEY & CO., INCORPORATED
To: KCI LICENSING, INC.
Reel/Frame 019617/0356 →
SECURITY AGREEMENT SUPPLEMENT Recorded Jan 27, 2005
From: KCI LICENSING, INC.
To: MORGAN STANLEY & CO. INCORPORATED
Reel/Frame 015613/0063 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2004
From: JOHNSON, ROYCE
To: KCI LICENSING, INC.
Reel/Frame 014829/0252 →